Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1197.86%
operating margin TTM
-731.49%
revenue TTM
7.34 Million
revenue per share TTM
1.31$
valuation ratios | |
|---|---|
| pe ratio | -6.10 |
| peg ratio | -0.12 |
| price to book ratio | 11.13 |
| price to sales ratio | 6.58 |
| enterprise value multiple | -1.22 |
| price fair value | 11.13 |
profitability ratios | |
|---|---|
| gross profit margin | 7.54% |
| operating profit margin | -731.49% |
| pretax profit margin | -1197.86% |
| net profit margin | -1197.86% |
| return on assets | -142.38% |
| return on equity | -163.95% |
| return on capital employed | -103.49% |
liquidity ratio | |
|---|---|
| current ratio | 3.33 |
| quick ratio | 2.81 |
| cash ratio | 1.86 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 277.28 |
| operating cycle | 407.01 |
| days of payables outstanding | 137.57 |
| cash conversion cycle | 269.43 |
| receivables turnover | 2.81 |
| payables turnover | 2.65 |
| inventory turnover | 1.32 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.06 |
| debt equity ratio | 0.08 |
| long term debt to capitalization | 0.07 |
| total debt to capitalization | 0.07 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -11.50 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.10 |
| cash per share | 0.45 |
| operating cash flow per share | -1.09 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -11.50 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -143.42 |
Frequently Asked Questions
When was the last time Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) reported earnings?
Tonix Pharmaceuticals Holding Corp. (TNXP) published its most recent earnings results on 12-11-2024.
What is Tonix Pharmaceuticals Holding Corp.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)'s trailing twelve months ROE is -163.95%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Tonix Pharmaceuticals Holding Corp. (TNXP) currently has a ROA of -142.38%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did TNXP's net profit margin stand at?
TNXP reported a profit margin of -1197.86% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is TNXP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 3.33 in the most recent quarter. The quick ratio stood at 2.81, with a Debt/Eq ratio of 0.08.